09 December 2025 : Clinical Research
Enhanced Eustachian Tube Function and Hearing Recovery with Combined Balloon Dilatation and Tympanic Membrane Catheterization in Secretory Otitis Media
Wenshuai Chang ABCDEF 1, Xiaoying Zhou ABCDEF 2*DOI: 10.12659/MSM.948981
Med Sci Monit 2025; 31:e948981
Table 3 Serum levels of procalcitonin (PCT), high-sensitivity C-reactive protein (hs-CRP), and interleukin-6 (IL-6) before and 6 months after treatment in the balloon plus catheterization group and balloon-only group (n=45, mean±SD).
| Group | Serum PCT (μg/L) | hs-CRP concentration (mg/L) | IL-6 (pg/mL) | |||
|---|---|---|---|---|---|---|
| Before treatment | After 6 months of treatment | Before treatment | After 6 months of treatment | Before treatment | After 6 months of treatment | |
| Balloon + catheterization | 8.63±0.45 | 0.92±0.11a | 6.44±0.45 | 2.13±0.19a | 126.48±23.42 | 47.44±3.08a |
| Balloon-only | 8.58±0.47 | 3.37±0.04b | 6.39±0.41 | 4.41±0.29b | 126.51±23.39 | 75.31±4.39b |
| t | 0.515 | 140.415 | 0.551 | 44.115 | 0.006 | 34.863 |
| >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 | |
| a b | ||||||